![Stephen Gould](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Gould
Nessuna posizione attualmente
Patrimonio netto: 622 $ in data 31/05/2024
Provenienza dei contatti di primo grado di Stephen Gould
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Stephen Gould tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
HUMANIGEN, INC. | Biotechnology | Chief Executive Officer | |
DNAtrix, Inc.
![]() DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Equipment/Instruments | Director/Board Member | |
AFFYMAX, INC. | Biotechnology | Director of Finance/CFO | |
Arthur Andersen LLP
![]() Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
JASPER THERAPEUTICS, INC. | Financial Conglomerates | Director of Finance/CFO | |
Loyola Marymount University | College/University | Undergraduate Degree | |
Sanofi-Aventis, Inc.
![]() Sanofi-Aventis, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Aventis, Inc. is a company that manufactures and wholesales pharmaceutical products. The company is based in Scottsdale, AZ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CLOVER BIOPHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Haas School of Business | College/University | Undergraduate Degree | |
APEXIGEN, INC. | Biotechnology | Director/Board Member | |
PDL BIOPHARMA, INC. | Biotechnology | Comptroller/Controller/Auditor | |
Apexigen America, Inc.
![]() Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Balance Therapeutics, Inc.
![]() Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Biotechnology | Director of Finance/CFO | |
ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director of Finance/CFO | |
School of Medicine University of Nevada | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 18 |
Australia | 2 |
Cina | 2 |
Settori
Health Technology | 13 |
Consumer Services | 4 |
Distribution Services | 2 |
Electronic Technology | 2 |
Commercial Services | 2 |
Posizioni
Director of Finance/CFO | 8 |
Comptroller/Controller/Auditor | 7 |
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Contatti più connessi
Insiders | |
---|---|
Herbert Cross | 14 |
Philippe C. Bishop | 9 |
- Borsa valori
- Insiders
- Stephen Gould
- Connessioni Società